Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T21:23:00.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page shows an updated revision version from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:36:27.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. It appears to be a minor site version update with no changes to study data or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-02-12T02:14:27.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The change updates the page revision label from v3.4.0 to v3.4.1, with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:26:00.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added Show glossary and metadata items: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous items Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T21:49:02.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision history updated: added v3.3.4 and removed v3.3.3. This is a metadata change and does not affect study details, page content, or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:57:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.